Helena Katrina Tayton-Martin Insider Trading $ADAP Adaptimmune Therapeutics PLC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Helena Katrina Tayton-Martin.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Helena Katrina Tayton-Martin. Helena Katrina Tayton-Martin is Chief Business Officer in Adaptimmune Therapeutics PLC ($ADAP) and Chief Operating Officer in Adaptimmune Therapeutics PLC ($ADAP).

Helena Katrina Tayton-Martin in Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Helena Katrina Tayton-Martin: Chief Business Officer, Chief Operating Officer
Holdings: 1,800,000 shares
Current Value: $8,154,000
Latest Transaction: Mar 03 2021
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Helena Katrina Tayton-Martin in Adaptimmune Therapeutics PLC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 03 2021ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...BuyM0.161,785,000280,2451,800,00015 K to 1.8 M (+11,900.00 %)
Jan 11 2021ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.00242,712340242,712
Jan 11 2021ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA1.031,086,8161,119,4201,086,816
Aug 04 2020ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...SellS8.74200,0001,748,1800200 K to 0 (-100.00 %)
Jan 17 2020ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.00280,896365280,896
Jan 17 2020ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.741,257,744930,7311,257,744
Jan 15 2020ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...SellS5.0050,000250,000050 K to 0 (-100.00 %)
Jan 15 2020ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...SellS4.0050,000200,000050 K to 0 (-100.00 %)
Jan 08 2019ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.00224,724292224,724
Jan 08 2019ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.00224,724292224,724
Jan 08 2019ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.891,006,224895,5391,006,224
Jan 08 2019ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.891,006,224895,5391,006,224
Jan 17 2018ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA0.00153,648215153,648
Jan 17 2018ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Business Offi ...Option ExerciseA1.30687,984894,379687,984
Jan 18 2017ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Operating Off ...Option ExerciseA0.722,072,9761,492,5432,072,976
Jan 20 2016ADAPAdaptimmune Therap ...TAYTON-MARTIN HELEN KATRINAChief Operating Off ...Option ExerciseA1.27939,9481,195,332939,948

Page:   1